Michal Kielbinski
Overview
Explore the profile of Michal Kielbinski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
69
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Siwiec M, Bobula B, Kielbinski M, Multan N, Hess G, Tokarski K
Pharmacol Rep
. 2024 Nov;
76(6):1377-1389.
PMID: 39487932
Background: The study examined the effects of 5-HT receptor activation on GABAergic transmission within the dentate gyrus and plasticity at the glutamatergic perforant path input. Methods: Immunofluorescence imaging was performed...
2.
Kielbinski M, Bernacka J
Pharmacol Rep
. 2024 Sep;
76(6):1242-1255.
PMID: 39235662
In recent years, fluorescent sensors are enjoying a surge of popularity in the field of neuroscience. Through the development of novel genetically encoded sensors as well as improved methods of...
3.
Bobula B, Bak J, Kania A, Siwiec M, Kielbinski M, Tokarski K, et al.
Pharmacol Biochem Behav
. 2024 Aug;
244():173849.
PMID: 39142357
Selective serotonin (5-HT) reuptake inhibitors (SSRIs) are commonly prescribed to women during pregnancy and breastfeeding despite posing a risk of adverse cognitive outcomes and affective disorders for the child. The...
4.
Rojek-Sito K, Meyza K, Ziegart-Sadowska K, Nazaruk K, Puscian A, Hamed A, et al.
PLoS Biol
. 2023 Nov;
21(11):e3002343.
PMID: 38029342
For social interaction to be successful, two conditions must be met: the motivation to initiate it and the ability to maintain it. This study uses both optogenetic and chemogenetic approaches...
5.
Wilczkowski M, Karwowska K, Kielbinski M, Zajda K, Pradel K, Drwiega G, et al.
Eur J Neurosci
. 2022 Dec;
58(12):4487-4501.
PMID: 36479859
Drug seeking is associated with the ventral tegmental area (VTA) dopaminergic (DA) activity. Previously, we have shown that brief optogenetic inhibition of VTA DA neurons with 1 s pulses delivered...
6.
Kielbinski M, Bernacka J, Zajda K, Wawrzczak-Bargiela A, Mackowiak M, Przewlocki R, et al.
J Neurochem
. 2022 Sep;
164(5):598-612.
PMID: 36161462
Noradrenergic neurotransmission is a critical mediator of stress responses. In turn, exposure to stress induces noradrenergic system adaptations, some of which are implicated in the etiology of stress-related disorders. Adrenergic...
7.
Solecki W, Kielbinski M, Wilczkowski M, Zajda K, Karwowska K, Joanna B, et al.
Front Neurosci
. 2022 Aug;
16:967969.
PMID: 35992934
Substance use disorder is linked to impairments in the ventral tegmental area (VTA) dopamine (DA) reward system. Noradrenergic (NA) inputs from locus coeruleus (LC) into VTA have been shown to...
8.
Solecki W, Kielbinski M, Bernacka J, Gralec K, Klasa A, Pradel K, et al.
Front Behav Neurosci
. 2022 Aug;
16:969104.
PMID: 35990723
Activity of the alpha-adrenergic receptor (α-AR) in the ventral tegmental area (VTA) modulates dopaminergic activity, implying its modulatory role in the behavioral functions of the dopamine (DA) system. Indeed, intra-VTA...
9.
Setkowicz Z, Gzielo K, Kielbinski M, Janeczko K
J Comp Neurol
. 2021 Dec;
530(9):1379-1398.
PMID: 34861050
Disturbances of the early stages of neurogenesis lead to irreversible changes in the structure of the mature brain and its functional impairment, including increased excitability, which may be the basis...
10.
Setkowicz Z, Kielbinski M, Gzielo K, Weglarz W, Janeczko K
Epilepsy Behav
. 2020 Jul;
111:107288.
PMID: 32702654
Disorders of neurogenesis at early developmental stages lead to irreversible structural and functional impairments of the brain. As further their consequences, increases in brain excitability and the development of drug-resistant...